Tuberculosis

CHA

Tag: Tuberculosis

Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests

Help us stop the profiteering on medical tests Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries. MSF and partners protest outside Danaher in Washington, DC, demanding price...

Read more

Patient Stories: Ensuring recovery through timely, accurate drug-resistant tuberculosis testing

Ahmad, 11, from Tatlay Aali, a town in Gujranwala district, Pakistan, was diagnosed with tuberculosis (TB) when he was just five years old. "We’d never heard about this disease, nobody from our family ever had it. At the same time,...

Read more

Tuberculosis: Increased diagnostic testing for drug resistance will enhance patients’ treatment outcome

Islamabad: On World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières (MSF) encourages medical service providers and practitioners in Pakistan to enhance drug resistant tuberculosis (DRTB) diagnosis by increasing the use of GeneXpert diagnostic testing among suspect tuberculosis (TB) cases. Additionally,...

Read more

MSF launches unprecedented project to tackle under-diagnosed tuberculosis among children

Tuberculosis (TB) in children is a silent scourge: one child dies of TB every three minutes and more than half of all children with TB are never diagnosed. Taking the opportunity of a set of new recommendations by the World...

Read more

Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options

endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis Paris, France; November 15, 2023 – Clinical trial results presented for the first time today at the Union World Conference on Lung Health...

Read more

MSF warns governments are failing to test, treat and prevent TB in children

Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease  Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF)  welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...

Read more

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease

The World Health Organization’s (WHO) 2023 Global Tuberculosis (TB) Report released today shows that the estimated global incidence of TB in 2022 remains unacceptably high, including for the more difficult to treat form of this disease, drug-resistant TB (DR-TB). With...

Read more

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...

Read more

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign  "Today's announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline, offers...

Read more

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Mumbai, 23 March 2023 – Today, the 2019 patent challenge by two tuberculosis (TB) survivors, Nandita Venkatesan and Phumeza Tisile, was successful: the Indian Patent Office rejected the US pharmaceutical corporation Johnson & Johnson’s (J&J) attempt to extend its monopoly...

Read more

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB

Delhi, 22 March 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) called on governments and donors today to speed up access to new, shorter, safer and more effective treatments* for drug-resistant tuberculosis (DR-TB), as well as the diagnostic tests needed...

Read more

Between life and living: Patients with drug-resistant tuberculosis (DR-TB) share stories of strength, support and suffering

India has the highest burden of both tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) based on estimates in the WHO Global TB Report 2022. The country accounts for 28 percent of the global TB burden.  In its clinic in Mumbai, MSF...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons